About: covid:PMC6535369

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:PMC6535369 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
Creator	Bok, Karin Excler, Jean-Louis Gurwith, Marc Singh, Vidisha Khuri-Bulos, Najwa Kochhar, Sonali Klug, Bettina Laderoute, Marian Robertson, James Seligman, Stephen Chen, Robert McNeil, Michael
is schema:about of	named entity 'immunization' named entity 'MONITORING' named entity 'World Health Organization' named entity 'attenuated virus' named entity 'pharmaceutical products' named entity 'post-marketing' named entity 'World Health Organization' named entity 'viruses' named entity 'line source' named entity 'vaccine' named entity 'upper bound' named entity 'VAERS' named entity 'acute disseminated encephalomyelitis' named entity 'fever' named entity 'statistical power' named entity 'clinical trials' named entity 'HVE' named entity 'Sweden' named entity 'vaccine' named entity 'observational studies' named entity 'VSD' named entity 'virus' named entity 'RCA' named entity 'viral vector' named entity 'public health' named entity 'cost-effective' named entity 'vaccine' named entity 'follow-up' named entity 'EMA' named entity 'immunization' named entity 'clinical studies' named entity 'antigen' named entity 'vaccine' named entity 'clinical development' named entity 'vector' named entity 'virulence' named entity 'follow-up' named entity 'virus' named entity 'immunization schedule' named entity 'infectious agent' named entity 'high-quality' named entity 'follow-up' named entity 'pre-clinical' named entity 'multiple testing' named entity 'viruses' named entity 'follow-up' named entity 'vaccination' named entity 'clinical development' named entity 'recombinant' named entity 'follow-up' named entity 'Gene Therapy' named entity 'LMIC' named entity 'EudraVigilance' named entity 'oncologic' named entity 'non-pregnant' named entity 'viruses' named entity 'adverse reactions' named entity 'immune response' named entity 'European Medicines Agency' named entity 'long-term' named entity 'clinical development' named entity 'Vaccine' named entity 'VAERS' named entity 'pharmaceutical product' named entity 'Adverse Event' named entity 'Gene Therapy' named entity 'febrile seizure' named entity 'follow-up' named entity 'antigens' named entity 'GBS' named entity 'CDC' named entity 'clinical trials' named entity 'pharmaceutical product' named entity 'vaccine' named entity 'pharmacovigilance' named entity 'vaccine' named entity 'vaccine' named entity 'follow-up' named entity 'antigen' named entity 'adverse events' named entity 'general population' named entity 'disease surveillance' named entity 'vaccination' named entity 'hematologic' named entity 'viral vectors' named entity 'adverse health outcomes' named entity 'FDA' named entity 'recombinant'

Attributes

Values

Creator

Bok, Karin
Excler, Jean-Louis
Gurwith, Marc
Singh, Vidisha
Khuri-Bulos, Najwa
Kochhar, Sonali
Klug, Bettina
Laderoute, Marian
Robertson, James
Seligman, Stephen
Chen, Robert
McNeil, Michael

is schema:about of

named entity 'immunization'
named entity 'MONITORING'
named entity 'World Health Organization'
named entity 'attenuated virus'
named entity 'pharmaceutical products'
named entity 'post-marketing'
named entity 'World Health Organization'
named entity 'viruses'
named entity 'line source'
named entity 'vaccine'
named entity 'upper bound'
named entity 'VAERS'
named entity 'acute disseminated encephalomyelitis'
named entity 'fever'
named entity 'statistical power'
named entity 'clinical trials'
named entity 'HVE'
named entity 'Sweden'
named entity 'vaccine'
named entity 'observational studies'
named entity 'VSD'
named entity 'virus'
named entity 'RCA'
named entity 'viral vector'
named entity 'public health'
named entity 'cost-effective'
named entity 'vaccine'
named entity 'follow-up'
named entity 'EMA'
named entity 'immunization'
named entity 'clinical studies'
named entity 'antigen'
named entity 'vaccine'
named entity 'clinical development'
named entity 'vector'
named entity 'virulence'
named entity 'follow-up'
named entity 'virus'
named entity 'immunization schedule'
named entity 'infectious agent'
named entity 'high-quality'
named entity 'follow-up'
named entity 'pre-clinical'
named entity 'multiple testing'
named entity 'viruses'
named entity 'follow-up'
named entity 'vaccination'
named entity 'clinical development'
named entity 'recombinant'
named entity 'follow-up'
named entity 'Gene Therapy'
named entity 'LMIC'
named entity 'EudraVigilance'
named entity 'oncologic'
named entity 'non-pregnant'
named entity 'viruses'
named entity 'adverse reactions'
named entity 'immune response'
named entity 'European Medicines Agency'
named entity 'long-term'
named entity 'clinical development'
named entity 'Vaccine'
named entity 'VAERS'
named entity 'pharmaceutical product'
named entity 'Adverse Event'
named entity 'Gene Therapy'
named entity 'febrile seizure'
named entity 'follow-up'
named entity 'antigens'
named entity 'GBS'
named entity 'CDC'
named entity 'clinical trials'
named entity 'pharmaceutical product'
named entity 'vaccine'
named entity 'pharmacovigilance'
named entity 'vaccine'
named entity 'vaccine'
named entity 'follow-up'
named entity 'antigen'
named entity 'adverse events'
named entity 'general population'
named entity 'disease surveillance'
named entity 'vaccination'
named entity 'hematologic'
named entity 'viral vectors'
named entity 'adverse health outcomes'
named entity 'FDA'
named entity 'recombinant'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software